LESLEY HOFER: Open Payments
NPI 1386146694 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $141 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| PFIZER INC. | 2 | $40 |
| ABBVIE INC. | 1 | $33 |
| Geron Corporation | 1 | $25 |
| Exelixis Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: RYBREVANT, PADCEV, EPKINLY, RYTELO, KEYTRUDA, CABOMETYX, Onivyde, KEYTRUDA QLEX.
Industry payments across KS — which companies pay providers there.
